STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Stereotaxis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $101.03M
- P/E (TTM)
- –
- Dividend yield
- –
Stereotaxis, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disposables Service and Accessories [Member] | $22.15M | $18.29M | $18.03M | $21.30M | $22.87M | $22.02M | $25.85M | $27.76M | $26.87M | – | 68.4% | +21.2% |
| Systems [Member] | $10.22M | $8.63M | $8.74M | $6.85M | $11.17M | $3.63M | $2.07M | $1.58M | $4.28M | – | 31.6% | +18.4% |
| Sublease [Member] | – | – | – | – | $986.00K | $986.12K | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US [Member] | $19.51M | $13.49M | $8.57M | $8.44M | $14.66M | $9.19M | $9.64M | $10.73M | $13.11M | $12.74M | 60.3% | +44.6% |
| United States | $12.87M | $13.43M | $18.20M | $19.71M | $20.36M | $17.44M | $19.27M | $18.61M | $18.04M | $19.42M | 39.7% | -4.2% |
From the segment and revenue-disaggregation notes of Stereotaxis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.